• Medicine
• Published in Renal failure 2008
• DOI:10.1080/08860220801964285

The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.

@article{Ebin2008TheRA,
  title={The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.},
  author={Fatma Ayerden Ebinç and Yasemin Erten and Haksun Ebinç and Hat{\^i}ce Paşaoğlu and Canan Yilmaz Demirtaş and G{\"u}lten Aydoğdu Taçoy and R{\"u}ya Mutluay and Ey{\"u}p Koç and Ulver Boztepe Derici and Kadriye Altok Reis and Musa Bali and Turgay Arınsoy and Ş{\"u}kr{\"u} Sindel},
  journal={Renal failure},
  year={2008},
  volume={30 4},
  pages={
          401-6
        }
}

• Fatma Ayerden Ebinç, Yasemin Erten, +10 authors Şükrü Sindel

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial-based nitric oxide synthase. Its level is increased by end stage renal disease. However, most studies showing an increase in ADMA in dialysis patients have focused on hemodialysis. Results with peritoneal dialysis patients have been more inconclusive. Recent studies suggest that ADMA may be a new cardiovascular risk factor. The aim of the present study was to evaluate the relationship between ADMA levels, residual… CONTINUE READING

View on PubMed

Open Access

Save to Library

Create Alert

Cite